Corcept Therapeutics, Inc. (CORT)

115.59 -0.64 (-0.55%) USD  |  NASDAQ  |  Oct 15, 10:53
More

Corcept Therapeutics Total Long Term Debt (Quarterly) : 7.504M for June 30, 2026

Total Long Term Debt (Quarterly) Chart

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 7.504M
March 31, 2026 8.01M
December 31, 2025 5.023M
September 30, 2025 5.308M
June 30, 2025 5.588M
March 31, 2025 5.851M
December 31, 2024 6.107M
September 30, 2024 6.359M
June 30, 2024 5.625M
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.552M
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.501M
September 30, 2020 0.997M
June 30, 2020 1.486M
Date Value
March 31, 2020 1.541M
December 31, 2019 1.903M
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 4.573M
March 31, 2017 10.11M
December 31, 2016 14.66M
September 30, 2016 18.72M
June 30, 2016 22.30M
March 31, 2016 25.04M
December 31, 2015 27.53M
September 30, 2015 29.64M
June 30, 2015 31.43M
March 31, 2015 32.78M
December 31, 2014 33.89M
September 30, 2014 34.65M
June 30, 2014 35.03M
March 31, 2014 35.11M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. 49.62B
Pfizer Inc. 63.10B
Illumina, Inc. 2.445B
Aclaris Therapeutics, Inc. 1.262M
Bristol Myers Squibb Co. 44.59B